Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
557
datasets available to search
ShareScore release 0.9.0
Dataset results
557 results for “Imatinib”
Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy
ClinicalTrials.gov study NCT00509093. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients
ClinicalTrials.gov study NCT00499889. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pazopanib in Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors (GIST)
ClinicalTrials.gov study NCT01391611. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian Origin
ClinicalTrials.gov study NCT00840450. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate
ClinicalTrials.gov study NCT00038675. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib for Pain in Sickle Cell Anemia
ClinicalTrials.gov study NCT03997903. IPD Sharing: NO. Countries: 1. Publications: 0.
Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor
ClinicalTrials.gov study NCT00685828. IPD Sharing: Not stated. Countries: 0. Publications: 7.
A Study of Imatinib and Docetaxel in Prostate Cancer
ClinicalTrials.gov study NCT00251225. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC)
ClinicalTrials.gov study NCT00424385. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With Imatinib
ClinicalTrials.gov study NCT04633122. IPD Sharing: NO. Countries: 1. Publications: 0.
Adjuvant Imatinib in High-risk Gastrointestinal Stromal Tumor (GIST) With C-kit Mutation
ClinicalTrials.gov study NCT00278876. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT01383447. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)
ClinicalTrials.gov study NCT00615927. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate in Treating Patients With Recurrent Meningioma
ClinicalTrials.gov study NCT00045734. IPD Sharing: NO. Countries: 1. Publications: 0.
Treatment of CML Patients With Imatinib and Hydroxyurea (CML2004)
ClinicalTrials.gov study NCT02480608. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Dasatinib or Nilotinib Followed by Imatinib in Patients With Newly Diagnosed, Chronic Phase Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT02709083. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Available Treatment Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and Nilotinib in Adults With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT05743465. IPD Sharing: YES. Countries: 1. Publications: 0.
Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator
ClinicalTrials.gov study NCT01742299. IPD Sharing: YES. Countries: 11. Publications: 0.
Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)
ClinicalTrials.gov study NCT00290771. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib.
ClinicalTrials.gov study NCT01289028. IPD Sharing: Not stated. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.